1. Home
  2. BHC vs CSQ Comparison

BHC vs CSQ Comparison

Compare BHC & CSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHC
  • CSQ
  • Stock Information
  • Founded
  • BHC N/A
  • CSQ 2003
  • Country
  • BHC Canada
  • CSQ United States
  • Employees
  • BHC N/A
  • CSQ N/A
  • Industry
  • BHC Biotechnology: Pharmaceutical Preparations
  • CSQ Finance Companies
  • Sector
  • BHC Health Care
  • CSQ Finance
  • Exchange
  • BHC Nasdaq
  • CSQ Nasdaq
  • Market Cap
  • BHC 3.0B
  • CSQ 2.8B
  • IPO Year
  • BHC N/A
  • CSQ N/A
  • Fundamental
  • Price
  • BHC $8.18
  • CSQ $17.93
  • Analyst Decision
  • BHC Hold
  • CSQ
  • Analyst Count
  • BHC 4
  • CSQ 0
  • Target Price
  • BHC $7.25
  • CSQ N/A
  • AVG Volume (30 Days)
  • BHC 2.0M
  • CSQ 220.3K
  • Earning Date
  • BHC 10-30-2024
  • CSQ 01-01-0001
  • Dividend Yield
  • BHC N/A
  • CSQ 7.53%
  • EPS Growth
  • BHC N/A
  • CSQ N/A
  • EPS
  • BHC N/A
  • CSQ N/A
  • Revenue
  • BHC $9,474,000,000.00
  • CSQ N/A
  • Revenue This Year
  • BHC $9.59
  • CSQ N/A
  • Revenue Next Year
  • BHC $3.53
  • CSQ N/A
  • P/E Ratio
  • BHC N/A
  • CSQ N/A
  • Revenue Growth
  • BHC 10.91
  • CSQ N/A
  • 52 Week Low
  • BHC $3.96
  • CSQ $12.50
  • 52 Week High
  • BHC $11.46
  • CSQ $16.45
  • Technical
  • Relative Strength Index (RSI)
  • BHC 41.53
  • CSQ 57.48
  • Support Level
  • BHC $8.15
  • CSQ $17.55
  • Resistance Level
  • BHC $8.36
  • CSQ $18.18
  • Average True Range (ATR)
  • BHC 0.28
  • CSQ 0.21
  • MACD
  • BHC -0.17
  • CSQ -0.02
  • Stochastic Oscillator
  • BHC 4.02
  • CSQ 70.00

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

About CSQ Calamos Strategic Total Return

Calamos Strategic Total Return Fund is a diversified, closed-end management investment company. The fund's investment strategy is to provide total return through a combination of capital appreciation and current income. Its investment portfolio consists of equities, convertible securities and high-yield corporate bonds.

Share on Social Networks: